Prevention of venous thromboembolism in cancer outpatients: guidance from the SSC of the ISTH

被引:55
作者
Khorana, A. A. [1 ]
Otten, H-M. [2 ]
Zwicker, J. I. [3 ,4 ]
Connolly, G. C. [5 ,6 ]
Bancel, D. F. [7 ,8 ]
Pabinger, I. [9 ]
机构
[1] Cleveland Clin Fdn, Taussig Canc Inst, Cleveland, OH 44195 USA
[2] Slotervaart Hosp, Dept Internal Med, Amsterdam, Netherlands
[3] Beth Israel Deaconess Med Ctr, Div Hemostasis & Thrombosis, Boston, MA 02215 USA
[4] Harvard Univ, Sch Med, Boston, MA USA
[5] Univ Rochester, James P Wilmot Canc Ctr, Rochester, NY USA
[6] Univ Rochester, Dept Med, Rochester, NY USA
[7] Hop St Louis, AP HP, Internal Med & Vasc Dis Unit, Paris, France
[8] Univ Paris 07, INSERM, U796, Paris, France
[9] Med Univ Vienna, Clin Div Hematol & Hemostaseol, Dept Med 2, Vienna, Austria
关键词
PATIENTS RECEIVING CHEMOTHERAPY; PHASE-II TRIAL; PANCREATIC-CANCER; RANDOMIZED-TRIAL; THROMBOPROPHYLAXIS; RISK; PROPHYLAXIS; ENOXAPARIN; PREDICTION; THROMBOSIS;
D O I
10.1111/jth.12725
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:1928 / 1931
页数:4
相关论文
共 24 条
[1]   Semuloparin for Thromboprophylaxis in Patients Receiving Chemotherapy for Cancer [J].
Agnelli, Giancarlo ;
George, Daniel J. ;
Kakkar, Ajay K. ;
Fisher, William ;
Lassen, Michael R. ;
Mismetti, Patrick ;
Mouret, Patrick ;
Chaudhari, Umesh ;
Lawson, Francesca ;
Turpie, Alexander G. G. .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (07) :601-609
[2]   Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study [J].
Agnelli, Giancarlo ;
Gussoni, Gualberto ;
Bianchini, Carlo ;
Verso, Melina ;
Mandala, Mario ;
Cavanna, Luigi ;
Barni, Sandra ;
Labianca, Roberto ;
Buzzi, Franco ;
Scambia, Giovanni ;
Passalacqua, Rodolfo ;
Ricci, Sergio ;
Gasparini, Giampietro ;
Lorusso, Vito ;
Bonizzoni, Erminio ;
Tonato, Maurizio .
LANCET ONCOLOGY, 2009, 10 (10) :943-949
[3]  
[Anonymous], 2012, COCHRANE DATABASE SY
[4]   Prediction of venous thromboembolism in cancer patients [J].
Ay, Cihan ;
Dunkler, Daniela ;
Marosi, Christine ;
Chiriac, Alexandru-Laurentiu ;
Vormittag, Rainer ;
Simanek, Ralph ;
Quehenberger, Peter ;
Zielinski, Christoph ;
Pabinger, Ingrid .
BLOOD, 2010, 116 (24) :5377-5382
[5]  
Baglin T, 2012, J THROMB HAEMOST, V10, P1702, DOI [10.1111/j.1538-7836.2012.04662.x, 10.1111/j.1538-7836.2012.04806.x]
[6]   Malignancies, prothrombotic mutations, and the risk of venous thrombosis [J].
Blom, JW ;
Doggen, CJM ;
Osanto, S ;
Rosendaal, FR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (06) :715-722
[7]   International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer [J].
Farge, D. ;
Debourdeau, P. ;
Beckers, M. ;
Baglin, C. ;
Bauersachs, R. M. ;
Brenner, B. ;
Brilhante, D. ;
Falanga, A. ;
Gerotzafias, G. T. ;
Haim, N. ;
Kakkar, A. K. ;
Khorana, A. A. ;
Lecumberri, R. ;
Mandala, M. ;
Marty, M. ;
Monreal, M. ;
Mousa, S. A. ;
Noble, S. ;
Pabinger, I. ;
Prandoni, P. ;
Prins, M. H. ;
Qari, M. H. ;
Streiff, M. B. ;
Syrigos, K. ;
Bounameaux, H. ;
Buller, H. R. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 (01) :56-70
[8]  
George D., 2011, ASH ANN M PROGR P
[9]   Development and validation of a predictive model for chemotherapy-associated thrombosis [J].
Khorana, Alok A. ;
Kuderer, Nicole M. ;
Culakova, Eva ;
Lyman, Gary H. ;
Francis, Charles W. .
BLOOD, 2008, 111 (10) :4902-4907
[10]   Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States [J].
Khorana, Alok A. ;
Dalal, Mehul ;
Lin, Jay ;
Connolly, Gregory C. .
CANCER, 2013, 119 (03) :648-655